| Intrinsic Valuation of: GEN | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 2 | Market Cap | $14B | |||||
| 2021 | - | - (-) | P/E Ratio | 15 | Total Asset | $15B | |||||
| 2022 | $968M | - (-) | Net Income | $643M | Total Debt | $8B | |||||
| 2023 | $751M | -22.4% (-34.6%) | EBITDA | $2B | Total Liab | $13B | |||||
| 2024 | $2B | 172.2% (137.6%) | Opr Margin | 41.17 | Debt/Equity | 3.51 | |||||
| 2025 | $1B | -41.0% (-43.0%) | PreTax Margin | 26.48 | BV/Share | -17 | |||||
| 5Y Average FCF | $1B | 15.0% (20.0%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.78% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | $1B | MBG Intrinsic Value | $14 | ||||||||
| 2027 | $2B | ||||||||||
| 2028 | $2B | ||||||||||
| 2029 | $2B | ||||||||||
| 2030 | $2B | ||||||||||
| 2031 | $2B | ||||||||||
| Terminal Value | $39B | Net Worth/Share | $4 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $33B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $1B | $43 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $8B | WACC | 6.5% | 48 | 53 | 60 | 69 | 80 | |||
| Equity Value | $26B | 7.3% | 40 | 43 | 48 | 53 | 60 | ||||
| Shares Outstanding | 605,663,774 | 8.1% | 33 | 36 | 39 | 43 | 48 | ||||
| 9.0% | 28 | 30 | 33 | 35 | 39 | ||||||
| DCF Intrinsic Value | $43 | 9.8% | 24 | 26 | 27 | 30 | 32 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||